Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor and/or Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05080790
What this trial is testing

Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 7
Very early researchActive Not RecruitingNCT04634227
What this trial is testing

Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)

Who this might be right for
SarcomaSoft Tissue SarcomaUnresectable Soft Tissue Sarcoma+2 more
University of Iowa 30
Early research (Phase 1)Ended earlyNCT02784795
What this trial is testing

LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerColon Cancer+2 more
Eli Lilly and Company 94
Early research (Phase 1)Looking for participantsNCT07156565
What this trial is testing

Actinium Therapy for Late-stage Aggressive Sarcomas

Who this might be right for
Advanced Soft Tissue Sarcoma
Ratio Therapeutics, Inc. 48
Testing effectiveness (Phase 2)Ended earlyNCT03132155
What this trial is testing

QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma

Who this might be right for
Clear Cell Sarcoma
NantPharma, LLC 8
Testing effectiveness (Phase 2)Study completedNCT01391962
What this trial is testing

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Who this might be right for
Sarcoma, Alveolar Soft Part
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)WithdrawnNCT00017160
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma

Who this might be right for
Stage III Adult Soft Tissue SarcomaRecurrent Adult Soft Tissue SarcomaStage IVA Adult Soft Tissue Sarcoma+2 more
Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650986
What this trial is testing

Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Melanoma+47 more
Roswell Park Cancer Institute 15
Early research (Phase 1)Study completedNCT00101270
What this trial is testing

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Ended earlyNCT01341496
What this trial is testing

Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal

Who this might be right for
SarcomaMelanomaEpithelial Malignancies+1 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT05277480
What this trial is testing

Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)

Who this might be right for
Effect of DrugDrugToxicity
Peking University People's Hospital 81
Testing effectiveness (Phase 2)Looking for participantsNCT07602049
What this trial is testing

Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma (STS)Osteosarcoma
Sun Yat-sen University 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT03660826
What this trial is testing

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Who this might be right for
Endometrial AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT03282344
What this trial is testing

NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Who this might be right for
SARCOMA
Memorial Sloan Kettering Cancer Center 88
Testing effectiveness (Phase 2)Ended earlyNCT00322881
What this trial is testing

Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer+1 more
Dana-Farber Cancer Institute 12
Testing effectiveness (Phase 2)WithdrawnNCT04464967
What this trial is testing

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Who this might be right for
Advanced Solid TumorMetastatic CancerHER2-positive Breast Cancer+14 more
NKGen Biotech, Inc.
Early research (Phase 1)Active Not RecruitingNCT03628209
What this trial is testing

Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma

Who this might be right for
OsteosarcomaOsteosarcoma in ChildrenOsteosarcoma Recurrent+1 more
H. Lee Moffitt Cancer Center and Research Institute 21
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Testing effectiveness (Phase 2)UnknownNCT05265793
What this trial is testing

Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma

Who this might be right for
PD-1 ImmunotherapyVEGFR-TKISarcomatoid Carcinoma+1 more
Fudan University 45
Early research (Phase 1)Active Not RecruitingNCT04511871
What this trial is testing

A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors

Who this might be right for
Solid TumorGastric CancerBreast Cancer+2 more
Shanghai PerHum Therapeutics Co., Ltd. 12
Next Page
288